Evidence map›Paper›PMID 34320167›Full record

ArticleCardiovascular research2021

NAD+ metabolism and cardiometabolic health: the human evidence.

Mahmoud Abdellatif, Joseph A Baur

Abstract readComment
In one paragraph

Article in Cardiovascular research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Maladaptive Immune Activation in Age-Related Decline of Muscle Function.The journals of gerontology. Series A, Biological sciences and medical sciences · 2023
    Review
  5. NADJournal of lipid and atherosclerosis · 2022
    Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Mahmoud AbdellatifDepartment of Cardiology, Medical University of Graz, Graz, Austria.ORCID 0000-0002-5042-9054
Joseph A BaurDepartment of Physiology and Institute for Diabetes, Obesity and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0001-8262-6549

Funding

Targeting NAD Metabolism to Improve Glucose Homeostasis in Obesity and AgingR01DK098656 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI Joseph A. Baur · 2013 to 2026
$6.1M
European Society of CardiologyKeith Michael Andrus Memorial AwardMetro International Biotech and Elysium HealthNIDDK NIH HHS R01 DK098656NIH HHS DK098656
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cardiovascular DiseasesNADHumansNiacinamideNADNiacinamideAgeingCardiovascular diseaseDiabetesNiacinNicotinamideNMNNRObesity

Identifiers

PMID34320167
PMCPMC8318105

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.